Medtech Talk
Newly Minted VC Stacy Enxing Seng Talks Medtech, Medtronic & Why She Joined Lightstone
Apr 28, 2016
25:16
Episode Description
Though initially surprised by Medtronic’s move to buy Covidien, Stacy Enxing Seng says she immediately saw the wisdom of the deal and recognized the opportunity for a fresh start. In an interview, Enxing Seng explains why she left, what she’s been doing, and how her new role at Lightstone Ventures fits her vision for Medtech’s future.

